Millennium Management’s Novo Nordisk NVO Stock Holding History

Millennium Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$70.2M	Buy	1,464,300 +708,700	+94%	+$30.4M	0.03%	703
2026 Q1	$27.8M	Sell	755,600 -1,110,200	-60%	-$52.6M	0.01%	1284
2025 Q4	$94.9M	Buy	1,865,800 +6,100	+0.3%	+$312K	0.04%	453
2025 Q3	$103M	Buy	1,859,700 +1,419,200	+322%	+$83.1M	0.04%	432
2025 Q2	$30.4M	Buy	440,500 +153,800	+54%	+$10.5M	0.01%	1184
2025 Q1	$19.9M	Buy	286,700 +246,600	+615%	+$20.4M	0.01%	1523
2024 Q4	$3.45M	Sell	40,100 -350,400	-90%	-$37.9M	﹤0.01%	3169
2024 Q3	$46.5M	Buy	390,500 +191,400	+96%	+$25.5M	0.02%	869
2024 Q2	$28.4M	Buy	+199,100	New	+$26.4M	0.01%	1200
2024 Q1	–	Sell	-10,000	Closed	-$1.03M	–	6503
2023 Q4	$1.03M	Hold	10,000	–	–	﹤0.01%	4140
2023 Q3	$909K	Sell	10,000 -30,000	-75%	-$2.64M	﹤0.01%	4249
2023 Q2	$3.24M	Buy	40,000 +25,400	+174%	+$2.07M	﹤0.01%	3063
2023 Q1	$1.16M	Buy	+14,600	New	+$1.04M	﹤0.01%	3950
2014 Q3	–	Sell	-13,600	Closed	-$314K	–	3910
2014 Q2	$314K	Buy	+13,600	New	+$300K	﹤0.01%	2847

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Millennium Management's NVO Position: Q2 2026 in Review

Millennium Management increased its Novo Nordisk (NVO) stake by 45% in Q2 2026, buying an estimated $26.9M and bringing the position to 2,035,939 shares worth $97.6M. The position accounts for 0.04% of the portfolio, ranked #523.

Millennium Management first reported a position in NVO in Q2 2013 and has held it in 47 quarters since. The position peaked at $309M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Millennium Management held 2,035,939 shares of Novo Nordisk worth $97.6M as of Q2 2026.
Millennium Management bought 627,086 Novo Nordisk shares in Q2 2026, an estimated $26.9M.
Novo Nordisk made up 0.04% of Millennium Management's portfolio in Q2 2026, its #523 holding.
Millennium Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 47 quarters since.
Millennium Management's Novo Nordisk position peaked at $309M in Q2 2024.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.